|
End-of-day quote
Canadian Securities Exchange
29/10/2026
|
5-day change | 1st Jan Change | ||
| 0.0250 CAD | 0.00% |
|
0.00% | -66.67% |
| Market Cap | 3.27M 2.34M 2.09M 1.93M 1.75M 223M 3.32M 23.04M 9.19M 116M 8.77M 8.58M 369M | P/E 2024 |
-1.85x | P/E 2025 | -3.69x |
|---|---|---|---|---|---|
| Enterprise Value | 4.77M 3.41M 3.06M 2.82M 2.55M 325M 4.85M 33.66M 13.43M 170M 12.81M 12.54M 539M | EV / Sales 2024 |
0.67x | EV / Sales 2025 | 0.89x |
| Free-Float |
82.94% | Yield 2024 * |
-
| Yield 2025 | - |
Canadian Securities ExchangeCAD
| Markets | Quality | ||
|---|---|---|---|
Canadian Securities Exchange
| HERB | End-of-day quote | |
Canadian Securities Exchange
| HERB | Delayed | |
|
OTC Markets
| LUFFF | Delayed | |
|
Deutsche Boerse AG
| HA9 | Delayed |
| 1 month | -28.57% | ||
| 3 months | -28.57% | ||
| 6 months | -58.33% | ||
| Current year | -66.67% |
| 1 week | 0.02 |  | 0.03 |
| 1 month | 0.02 | | 0.04 |
| Current year | 0.02 | | 0.12 |
| 1 year | 0.02 | | 0.13 |
| 3 years | 0.02 | | 0.13 |
| 5 years | 0.02 | | 0.25 |
| 10 years | 0.02 | | 9.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Philip Campbell
CEO | Chief Executive Officer | - | 14/05/2020 |
Jason Vandenberg
DFI | Director of Finance/CFO | 49 | 17/01/2022 |
Aron Tegenfeldt
PRN | Corporate Officer/Principal | - | 31/07/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Philip Campbell
BRD | Director/Board Member | - | 14/05/2020 |
Drew Malcolm
BRD | Director/Board Member | - | 23/06/2020 |
Herb Dhaliwal
CHM | Chairman | 73 | 22/04/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 23/09/26 | Buy | Chairman | 200,000 | 0.1530% | ||
| 14/09/26 | Buy | Chairman | 100,000 | 0.0779% | ||
| 02/09/26 | Buy | Chairman | 100,000 | 0.0779% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | -68.75% | -50.00% | 2.33M | |
| +6.63% | +5.13% | +68.86% | +145.20% | 1,148B | |
| +1.53% | +2.84% | +47.48% | +89.01% | 652B | |
| +1.68% | +1.96% | +29.16% | +109.31% | 505B | |
| +0.73% | +2.47% | +53.85% | +68.96% | 384B | |
| +3.83% | -0.62% | +69.01% | +42.32% | 348B | |
| +2.38% | +4.27% | +33.81% | +57.95% | 294B | |
| +2.26% | +3.47% | +5.21% | +28.92% | 264B | |
| +1.97% | +3.01% | +57.91% | +76.14% | 244B | |
| +4.03% | +5.36% | +39.76% | +116.14% | 197B | |
| Average | +2.11% | +1.25% | +33.63% | +68.40% | 403.72B | |
| Weighted average by Cap. | +2.25% | +1.50% | +50.23% | +95.97% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 9.92M 7.1M 6.36M 5.86M 5.31M 676M 10.08M 69.96M 27.91M 354M 26.63M 26.07M 1.12B | 12.12M 8.67M 7.77M 7.16M 6.48M 826M 12.32M 85.48M 34.1M 432M 32.54M 31.85M 1.37B |
| Net income | -2.77M -1.98M -1.78M -1.64M -1.48M -189M -2.82M -19.55M -7.8M -98.84M -7.44M -7.28M -313M | -1.84M -1.32M -1.18M -1.09M -985K -125M -1.87M -12.98M -5.18M -65.63M -4.94M -4.84M -208M |
| Net Debt | 1.37M 983K 881K 813K 735K 93.63M 1.4M 9.69M 3.87M 49M 3.69M 3.61M 155M | 1.51M 1.08M 964K 890K 805K 103M 1.53M 10.61M 4.23M 53.66M 4.04M 3.95M 170M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/10/26 | CA$0.0250 | 0.00% | 108,000 |
| 28/10/26 | CA$0.0250 | -16.67% | 91,000 |
| 27/10/26 | CA$0.0300 | +20.00% | 5,000 |
| 26/10/26 | CA$0.0250 | 0.00% | 14,100 |
| 23/10/26 | CA$0.0250 | 0.00% | 157,000 |
- Stock Market
- Stocks
- HERB Stock
Select your edition
All financial news and data tailored to specific country editions
